NetraMark

NetraMark

NetraMark is a Toronto-based machine learning software company founded by Joseph Geraci in 2015.

All edits by  Khadidiatou Amirou 

Edits on 1 Aug, 2020
Khadidiatou Amirou
Khadidiatou Amirou edited on 1 Aug, 2020
Edits made to:
Article (+18/-18 characters)
Article

Netramark's services are composed of its three proprietary technologies: NetraplayNetraPlay, NetraAI, and DeepCrush. NetraplayNetraPlay functions as an interface that allows users to determine and manipulate data inputs and outputs through the use of augmented intelligence. NetraAI is a machine learning tool intended to analyze small datasets, although when DeepCrush's functionality is activated, it is able to analyze datasets of all sizes and classify them based on identified correlates. In Netramark's NetraPharma venture, all of these technologies are employed alongside NetraHealthAtlas, a repository of pharmacological-related data.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 1 Aug, 2020
Edits made to:
Article (+7/-7 characters)
Article

Netramark is a company developing machine learning-based software-as-a-service (SaaS). It was founded in 2015 by Joseph Geraci and Richard Brooks. The company also entered into a joint venture with Juvenescence AI in 2018 under the name of NetraPharma, which focuses on establishing a computational drug discovery platform. Netramark is headquartered in TorontoToronto, Ontario, Canada.

Khadidiatou Amirou
Khadidiatou Amirou edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Article (+19 characters)
Article

Netramark is a company developing machine learning-based software-as-a-service (SaaS). It was founded in 2015 by Joseph Geraci and Richard Brooks. The company also entered into a joint venture with Juvenescence AI in 2018 under the name of NetraPharma, which focuses on establishing a computational drug discovery platform. Netramark is headquartered in Toronto, Ontario, Canada.

Infobox
Founder
Richard Brooks (entrepreneur)
Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 1 Aug, 2020
Edits made to:
Article (+4/-4 characters)
Article

Netramark is a company developing machine learning-based software-as-a-service (SaaSSaaS). It was founded in 2015 by Joseph Geraci. The company also entered into a joint venture with Juvenescence AI in 2018 under the name of NetraPharma, which focuses on establishing a computational drug discovery platform. Netramark is headquartered in Toronto, Ontario, Canada.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 1 Aug, 2020
Edits made to:
Article (+13/-13 characters)
Article

Netramark is a company developing machine learning-based software-as-a-service (SaaS). It was founded in 2015 by Joseph Geraci. The company also entered into a joint venturejoint venture with Juvenescence AI in 2018 under the name of NetraPharma, which focuses on establishing a computational drug discovery platform. Netramark is headquartered in Toronto, Ontario, Canada.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 1 Aug, 2020
Edits made to:
Article (+16/-16 characters)
Article

Netramark's services are composed of its three proprietary technologies: Netraplay, NetraAI, and DeepCrush. Netraplay functions as an interface that allows users to determine and manipulate data inputs and outputs through the use of augmented intelligence. NetraAI is a machine learningmachine learning tool intended to analyze small datasets, although when DeepCrush's functionality is activated, it is able to analyze datasets of all sizes and classify them based on identified correlates. In Netramark's NetraPharma venture, all of these technologies are employed alongside NetraHealthAtlas, a repository of pharmacological-related data.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 1 Aug, 2020
Edits made to:
Article (+7/-7 characters)
Article

Netramark is a company developing machine learning-based software-as-a-service (SaaS). It was founded in 2015 by Joseph Geraci. The company also entered into a joint venture with Juvenescence AI in 2018 under the name of NetraPharma, which focuses on establishing a computational drug discovery platform. Netramark is headquartered in Toronto, OntarioOntario, Canada.

Khadidiatou Amirou
Khadidiatou Amirou edited on 1 Aug, 2020
Edits made to:
Infobox (+4/--1 properties)
Infobox
CEO
Joseph Geraci
Company status
Active
Founder
Joseph Geraci
Khadidiatou Amirou
Khadidiatou Amirou edited on 1 Aug, 2020
Edits made to:
Description (+96/-99 characters)
Article (+1004 characters)
People (+7 rows) (+14 cells) (+150 characters)
Further reading (+3 rows) (+8 cells) (+527 characters)
Topic thumbnail

NetraMark

A company using quantum machine learning to help pharmaceutical companies with clinical trials and

NetraMark is a Toronto-based machine learning software company founded by Joseph Geraci in 2015.

Article

Netramark is a company developing machine learning-based software-as-a-service (SaaS). It was founded in 2015 by Joseph Geraci. The company also entered into a joint venture with Juvenescence AI in 2018 under the name of NetraPharma, which focuses on establishing a computational drug discovery platform. Netramark is headquartered in Toronto, Ontario, Canada.

...
Product and service

Netramark's services are composed of its three proprietary technologies: Netraplay, NetraAI, and DeepCrush. Netraplay functions as an interface that allows users to determine and manipulate data inputs and outputs through the use of augmented intelligence. NetraAI is a machine learning tool intended to analyze small datasets, although when DeepCrush's functionality is activated, it is able to analyze datasets of all sizes and classify them based on identified correlates. In Netramark's NetraPharma venture, all of these technologies are employed alongside NetraHealthAtlas, a repository of pharmacological-related data.

People

Name
Role
LinkedIn

Bernard Wong

Employee

Jalal Ziauddin

Employee

John Chung

Employee

Joseph Geraci

Founder

Rafi Dowla

Employee

Richard Brooks

Employee

Shashibushan Yenkanchi

Employee

Further reading

Title
Author
Link
Type
Date

Classical and Quantum Machine Learning Applied To Predicting Placebo

Response For Clinical Trials In Bipolar Disorder: Recent Results

Joseph Geraci, Bernard Wong, Jalal Ziauddin, Siddhant Jain, Paul Leonczyk, Kim I. Bishop

NetraMark: Next-Gen AI for Disease Definition, Patient Stratification,

and Placebo Effect

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.